Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Republican lawmaker charged with insider trading will seek re-election

Published 09/17/2018, 04:05 PM
Updated 09/17/2018, 04:05 PM
© Reuters. FILE PHOTO: U.S. Representative Chris Collins is interviewed during the 2017 "Congress of Tomorrow" Joint Republican Issues Conference in Philadelphia, Pennsylvania, U.S.

(Reuters) - Republican U.S. Representative Chris Collins, who has been charged with taking part in an insider trading scheme, will stay on the ballot in November after reversing a decision to suspend his campaign, a New York Republican official said on Monday.

Collins' decision to seek a fourth two-year term could potentially boost Democrats' chances for winning a western New York district that had been considered solidly Republican.

Democrats need to flip 23 Republican-held seats in the Nov. 6 congressional elections to take control of the 435-seat House of Representatives, which would increase oversight of the Trump administration and likely stymie much of its legislative agenda.

Collins, 68, the first member of Congress to endorse Donald Trump's presidential bid in 2016, said last month he would suspend his campaign, although he has denied the charges against him.

But following advice from his legal team, Collins has decided to remain the Republican nominee, Erie County Republican Chairman Nick Langworthy told reporters. Under New York election laws, removing the name of a candidate from the ballot is a difficult process.

Collins' attorneys did not immediately respond to a request for comment.

"This comes as a disappointment to Republican leaders, myself along with others across this district," Langworthy said. "We thought it would be better to offer voters a choice of a candidate that did not face a distraction of a legal defense at this time."

Federal prosecutors have accused Collins, who sat on the board of a biotechnology company, of providing inside information about the results of a drug trial to his son and others.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Collins' case is unlikely to reach trial until next year, and Langworthy said he would expect Collins to step down if he wins election and is then convicted.

The county Republicans will not be spending money on Collins' re-election bid because they had already reached spending limits on federal races, the Republican official said.

Nate McMurray, Collins' Democratic challenger, called the original plan to replace Collins on the ballot "a sham" and said in a statement he was excited to continue campaigning against Collins.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.